# Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions

> **NCT04539886** · NA · COMPLETED · sponsor: **Pulse Biosciences, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Skin Lesion
- Skin Abnormalities
- Sebaceous Hyperplasia

## Interventions

- **DEVICE:** CellFX System
- **DEVICE:** Intralesional Electrodesiccation

## Key facts

- **NCT ID:** NCT04539886
- **Lead sponsor:** Pulse Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-28
- **Primary completion:** 2021-02-02
- **Final completion:** 2021-11-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04539886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04539886, "Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04539886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*